Insulin Dosing for Hyperglycemia in the Emergency Department
For adult patients presenting to the ED with non-emergent hyperglycemia, initiate subcutaneous rapid-acting insulin (insulin aspart) every 2 hours when blood glucose is ≥200 mg/dL, using a weight-based dosing approach of 0.1-0.25 U/kg for insulin-naive patients or those with mild hyperglycemia. 1
Clinical Approach Based on Severity
Mild Hyperglycemia (Blood Glucose <200 mg/dL)
- Use correction doses only with rapid-acting insulin before meals or every 6 hours
- Consider low-dose basal insulin (0.1 U/kg/day) if patient will be admitted
- For patients without diabetes or with good baseline control, sliding scale insulin alone may be sufficient 1
Moderate Hyperglycemia (Blood Glucose 201-300 mg/dL)
- Start basal insulin at 0.2-0.3 U/kg/day if admission is anticipated
- Add correction doses with rapid-acting insulin every 2 hours in the ED 2
- This approach achieves mean glucose reduction from 304 mg/dL to 217 mg/dL without prolonging ED length of stay 2
Severe Hyperglycemia (Blood Glucose >300 mg/dL)
- Initiate basal-bolus regimen with total daily dose of 0.3 U/kg/day
- Give half as basal insulin and half as bolus (divided before meals)
- For patients on high-dose insulin at home (≥0.6 U/kg/day), reduce their home dose by 20% 1
Practical ED Protocol
The most effective ED approach uses subcutaneous insulin aspart every 2 hours until blood glucose drops below 200 mg/dL 3, 2. This protocol:
- Reduces mean glucose from 333 mg/dL to 158 mg/dL by ED discharge
- Does not prolong ED length of stay (5.4 hours vs 4.9 hours for usual care)
- Results in shorter subsequent hospital stays (3.8 days vs 5.3 days) 3
Dosing Specifics
- For every 10 units of subcutaneous insulin, expect approximately 33 mg/dL glucose reduction 4
- Doses >5 units are associated with greater glucose reduction (37.4 mg/dL more) compared to ≤5 units 5
- Check blood glucose every 2 hours until target is reached
Critical Considerations
Avoid These Pitfalls
- Do NOT use sliding scale insulin alone in patients with known diabetes requiring admission—this leads to inadequate control 1
- Avoid premixed insulin (70/30) due to unacceptably high hypoglycemia rates 1
- Do NOT use intravenous insulin for non-emergent hyperglycemia—it increases hypokalemia risk (7.9%) without improving ED length of stay 5
- Limit IV fluids for glucose reduction alone—each liter adds 45 minutes to ED stay with only 27 mg/dL glucose reduction 4
Safety Monitoring
- Hypoglycemia risk with this protocol is low (7.4% develop glucose <70 mg/dL) 3
- Monitor potassium if using IV insulin (7.9% hypokalemia rate) 5
- Reduce starting doses to 0.15 U/kg/day in elderly patients (>65 years), those with renal failure, or poor oral intake 1
For Critically Ill Patients
If the patient meets criteria for critical illness or ICU admission, initiate continuous IV insulin infusion when blood glucose is persistently ≥180 mg/dL (two consecutive readings) 6. Target glucose range of 140-200 mg/dL rather than tight control to minimize hypoglycemia risk 6.
Transition Planning
If admitting the patient, start long-acting basal insulin (detemir or glargine) in the ED to ensure continuity of glycemic control 2. This combined ED-to-inpatient protocol achieves significantly better hospital glucose control (163 mg/dL vs 202 mg/dL patient-day weighted mean) without increasing hypoglycemia 2.